New York State Common Retirement Fund’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,600
| Closed | -$15K | – | 3243 |
|
|
2025
Q1 | $15K | Hold |
12,600
| – | – | ﹤0.01% | 3023 |
|
|
2024
Q4 | $16K | Hold |
12,600
| – | – | ﹤0.01% | 3075 |
|
|
2024
Q3 | $35K | Sell |
12,600
-32,900
| -72% | -$91.4K | ﹤0.01% | 2955 |
|
|
2024
Q2 | $103K | Buy |
+45,500
| New | +$103K | ﹤0.01% | 2775 |
|
|
2021
Q3 | – | Sell |
-259
| Closed | -$1K | – | 3415 |
|
|
2021
Q2 | $1K | Sell |
259
-24,041
| -99% | -$92.8K | ﹤0.01% | 3409 |
|
|
2021
Q1 | $53K | Hold |
24,300
| – | – | ﹤0.01% | 3206 |
|
|
2020
Q4 | $54K | Hold |
24,300
| – | – | ﹤0.01% | 3177 |
|
|
2020
Q3 | $65K | Hold |
24,300
| – | – | ﹤0.01% | 3087 |
|
|
2020
Q2 | $74K | Hold |
24,300
| – | – | ﹤0.01% | 3093 |
|
|
2020
Q1 | $48K | Hold |
24,300
| – | – | ﹤0.01% | 2990 |
|
|
2019
Q4 | $69K | Hold |
24,300
| – | – | ﹤0.01% | 3081 |
|
|
2019
Q3 | $89K | Sell |
24,300
-8,900
| -27% | -$32.6K | ﹤0.01% | 3062 |
|
|
2019
Q2 | $138K | Buy |
+33,200
| New | +$138K | ﹤0.01% | 2990 |
|
|
2016
Q1 | – | Sell |
-10,200
| Closed | -$17K | – | 3148 |
|
|
2015
Q4 | $17K | Hold |
10,200
| – | – | ﹤0.01% | 3156 |
|
|
2015
Q3 | $24K | Sell |
10,200
-10,740
| -51% | -$25.3K | ﹤0.01% | 3146 |
|
|
2015
Q2 | $57K | Buy |
20,940
+10,740
| +105% | +$29.2K | ﹤0.01% | 3189 |
|
|
2015
Q1 | $34K | Buy |
+10,200
| New | +$34K | ﹤0.01% | 2254 |
|